SynthesisMedicine2020

Durvalumab and tremelimumab combination therapy versus durvalumab or tremelimumab monotherapy for patients with solid tumors: A systematic review and meta-analysis.

Bi-Cheng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.